C9orf95 (NMRK1) (NM_017881) Human Untagged Clone

CAT#: SC320608

NMRK1 (untagged)-Human chromosome 9 open reading frame 95 (C9orf95), transcript variant 1

Specifications

Product Data

• Type: Human Untagged Clone
• Tag: Tag Free
• Symbol: NMRK1
• Synonyms: bA235O14.2; C9orf95; NRK1
• Vector: pCMV6-AC
• E. coli Selection: Ampicillin (100 ug/mL)
• Mammalian Cell Selection: Neomycin
• Sequence Data:
  Fully Sequenced ORF

  >OriGene sequence for NM_017881.1 GGGAAAGGGGCTGTGGGCCTCTCGGGGAGCGAGCTGCGGGTAGCGGCGCACTGGGTACAG
  GCGCGCGCTTGGCTGTCGCCTCTGCCGCTGTGTTTGGGAGGACTCGAACTGGCGCCAGGA
  AATATTAGGAAGCTGCGATTTTCAAAGCTAATTATGAAAACATTTATCATTGGAATCAGT
  GGTGTGACAAACAGTGGCAAAACAACACTGGCTAAGAATTTGCAGAAACACCTCCCAAAT
  TGCAGTGTCATATCTCAGGATGATTTCTTCAAGCCAGAGTCTGAGATAGAGACAGATAAA
  AATGGATTTTTGCAGTACGATGTGCTTGAAGCACTTAACATGGAAAAAATGATGTCAGCC
  ATTTCCTGCTGGATGGAAAGCGCAAGACACTCTGTGGTATCAACAGACCAGGAAAGTGCT
  GAGGAAATTCCCATTTTAATCATCGAAGGTTTTCTTCTTTTTAATTATAAGCCCCTTGAC
  ACTATATGGAATAGAAGCTATTTCCTGACGATTCCATATGAAGAATGTAAAAGGAGGAGG
  AGTACAAGGGTCTATCAGCCTCCAGACTCTCCGGGATACTTTGATGGCCATGTGTGGCCC
  ATGTATCTAAAGTACAGACAAGAAATGCAGGACATCACATGGGAAGTTGTGTACCTGGAT
  GGAACAAAATCTGAAGAGGACCTCTTTTTGCAAGTATATGAAGATCTAATACAAGAACTA
  GCAAAGCAAAAGTGTTTGCAAGTGACAGCATAAAGACGGAACACAACAAATCCTTCCTGA
  AGTGAATTAGGAAACTCCAAGGAGTAATTTAAGAACCTTCACCAAGATACAATGTATACT
  GTGGTACAATGACAGCCATTGTTTCATATGTTTGATTTTTATTGCACATGGTTTTCCCAA
  CATGTGGAACAATAAATATCCATGCCAATGGCCAGGACTGTACCTTAGCAAGTTGCTCCC
  TCTCCAGGGAGCGCATAGATACAGCAGAGCTCACAGTGAGTCAGAAAGTCTCCACTTTCT
  GAACATAGCTCTATAACAATGATTGTCAAACTTTTCTAACTGGAGCTCAGAGTAAGAAAT
  AAAGATTACATCACAATCCAAAAAAAAAAAAAAAAAAA
  5' Read Nucleotide Sequence

  >OriGene 5' read for NM_017881.1 unedited
  CACATTGTATACGACTCCTATAGGGCGGCCGGGAATTCGGCACGAGGGGGAAAGGGGCTG
  TGGGCCTCTCGGGGAGCGAGCTGCGGGTAGCGGCGCACTGGGTACAGGCGCGCGCTTGGC
  TGTCGCCTCTGCCGCTGTGTTTGGGAGGACTCGAACTGGCGCCAGGAAATATTAGGAAGC
  TGCGATTTTCAAAGCTAATTATGAAAACATTTATCATTGGAATCAGTGGTGTGACAAACA
  GTGGCAAAACAACACTGGCTAAGAATTTGCAGAAACACCTCCCAAATTGCAGTGTCATAT
  CTCAGGATGATTTCTTCAAGCCAGAGTCTGAGATAGAGACAGATAAAAATGGATTTTTGC
  AGTACGATGTGCTTGAAGCACTTAACATGGAAAAAATGATGTCAGCCATTTCCTGCTGGA
  TGGAAAGCGCAAGACACTCTGTGGTATCAACAGACCAGGAAAGTGCTGAGGAAATTCCCA
  TTTTAATCATCGAAGGTTTTCTTCTTTTTAATTATAAGCCCCTTGACACTATATGGAATA
  GAAGCTATTTCCTGACGATTCCATATGAAGAATGTAAAAGGAGGAGGAGTACAAGGGTCT
  ATCAGCCTCCAGACTCTCCGGGATACTTTGATGGCCATGTGTGGCCCATGTATCTAAAGT
  ACAGACAAGAAATGCAGGACATCACATGGGAAGTTGTGTACCTGGATGGAACAAAATCTG
  AAGAGGACCTCTTTTTGCAAGTATATGAAGATCTAATACAAGAACTAGCAAAGCAAAAGT
  GTTTGCAAGTGACAGCATAAGACGGAACCACAACAAATCCTTCCTGAGTGAATTAGGAAA
  CTCCAAGGAGTAATTAGACCTTCACCAAGATAACATGTATACTGTGTACATGACAGCATT
  GTTCATATGTTTGATTTTTATTGCACATGGTTTTCCAACATGTGGCAC
• Restriction Sites: Please inquire
• ACCN: NM_017881
• ORF Size: 600 bp
• OTI Disclaimer: Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
• OTI Annotation: This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.

Reference Data

• RefSeq: NM_017881.1, NP_060351.1
• RefSeq Size: 1172
• RefSeq ORF: 600
• Locus ID: 54981
• Protein Pathways: Nicotinate and nicotinamide metabolism
• Gene Summary: Nicotinamide adenine dinucleotide (NAD+) is essential for life in all organisms, both as a coenzyme for oxidoreductases and as a source of ADP-ribosyl groups used in various reactions. Nicotinic acid and nicotinamide, collectively known as niacin, are the vitamin precursors of NAD+. Nicotinamide riboside kinases, such as NRK1, function to synthesize NAD+ through nicotinamide mononucleotide using nicotinamide riboside as the precursor (Bieganowski and Brenner, 2004 [PubMed 15137942]). [supplied by OMIM, Mar 2008]